Discount || Aarkstore.in || Drug Discovery and Development Market in Asia - Partnerships
Applications Of Bioinformatics In Drug Discovery And Process
Drug Rehab Programs In Florida
Drug Discovery in Rare Diseases
Initiating Rare Disease Drug Discovery Projects
Changing Paradigms in Drug Discovery : Scientific Business Intelligence and Workflow Solutions
6 Months Project Based Training in Dot Net
6 Months Project Based Training in J2EE
Top BBA Institute in Delhi,Bachelor of Business Administration in NCR,Management Programs in NCR,BBA Colleges in NCR, BBA Institute in NCR,Colleges for BBA in Delhi Noida,BBA Institute in Noida NCR
Risk Analysis for Portfolio of Drug Development Programs
Advances in genomics and combinatorial chemistry during the past two decades inspired innovative technologies and changes in the discovery and pre-clinical development paradigm with the goal of accelerating the process of bringing therapeutic drugs to market. Written by William Kisaalita, one of the foremost experts in this field, 3D Cell-Based Biosensors in Drug Discovery Programs: Microtissue Engineering for High Throughput Screening provides the latest information — from theory to practice — on challenges and opportunities for incorporating 3D cell-based biosensors or assays in drug discovery programs.
The book supplies a historical perspective and defines the problem 3D cultures can solve. It also discusses how genomics and combinatorial chemistry have changed the way drug are discovered and presents data from the literature to underscore the less-than-desirable pharmaceutical industry performance under the new paradigm. The author uses results from his lab and those of other investigators to show how 3D micro environments create cell culture models that more closely reflect normal in vivo-like cell morphology and function. He makes a case for validated biomarkers for three-dimensionality in vitro and discusses the advantages and disadvantages of promising tools in the search of these biomarkers. The book concludes with case studies of drugs that were abandoned late in the discovery process, which would have been discarded early if tested with 3D cultures.
Dr. Kisaalita presents evidence in support of embracing 3D cell-based systems for widespread use in drug discovery programs. He goes to the root of the issue, establishing the 3D cell-based biosensor physiological relevance by comparing 2D and 3D culture from genomic to functional levels. He then assembles the bioengineering principles behind successful 3D cell-based biosensor systems. Kisaalita also addresses the challenges and opportunities for incorporating 3D cell-based biosensors or cultures in current discovery and pre-clinical development programs. This book makes the case for widespread adoption of 3D cell-based systems, rendering their 2D counterparts, in the words of Dr. Kisaalita "quaint, if not archaic" in the near future.
Use coupon below to get discount at eCampus.com!
$3 off textbook orders over $75
$4 off textbook orders over $90
$5 off textbook orders over $100
Copy the coupon code before clicking the button!
|Amazon US||Paperback||$59.95 - $145.95|
A Single Source on Parallel Synthesis for Lead OptimizationThe end of the previous millennium saw an explosion in the application of parallel synthesis techniques for making compounds for ...
Describes the contribution of imaging modalities to the various stages of drug discovery and development, from early target validation to their use in clinical development programs. This title ...
Integrating various technologies with informational systems provides vast improvements to the overall research and development that occur in the biopharmaceutical industry. One of the first books to ...
The development of suitable assays, the integration of appropriate technology, and the effective management of the essential infrastructure are all critical to the success of any high-throughput ...
An integrated overview of modern approaches to lead discovery. Lead generation is increasingly seen as a distinct and success-determining phase of the drug discovery process. Over recent years, there ...
This book covers the science and approaches of enzyme inhibition applied in drug discovery and drug development, including both pharmacology and pharmacokinetic aspects of enzyme inhibition. ...
An ideal text for biotechnologists, protein chemists, and biochemists, Functional Protein Microarrays in Drug Discovery explores all aspects of functional protein microarrays, including basic ...
Covers powerful new tools for drug development. Molecular pathology offers tools and techniques that can greatly enhance the drug discovery and development process, helping to make the promises of ...
Early characterization of toxicity and efficacy would significantly impact the overall productivity of pharmaceutical R&D and reduce drug candidate attrition and failure. By describing the available ...
This work presents a comprehensive contemporary framework for approaching target validation in drug discovery. It begins with a detailed description of new enabling technologies, including aptamers, ...